Katheryn Grossman

Director, Clinical Development at Biohaven Pharmaceuticals

No bio yet


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Biohaven Pharmaceuticals

6 followers

Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.


Industries

Employees

501-1,000

Links